HealthTech

Ultromics

Ultromics raises $55M Series C at $300M valuation

$55M
Total Raised
Series C
Latest Round
2017
Founded
120+
Employees
Oxford, UK
1 min read

Quick Facts

Valuation
$300M
Latest Round Size
$55M
Latest Round Date
January 2025

Ultromics: Series C Funding Round

Ultromics has successfully raised $55M in Series C funding, reaching a valuation of $300M.

Company Overview

AI for cardiac imaging

Funding Details

The Series C round was led by Optum Ventures, with participation from Oxford Science Enterprises.

Company Information

  • Headquarters: Oxford, UK
  • Founded: 2017
  • Employees: 120+
  • Category: HealthTech

Investment

Ultromics plans to use the funds to accelerate product development, expand its team, and scale operations globally.

About the Investors

  • Optum Ventures: Verified investor in Series C
  • Oxford Science Enterprises: Verified investor in Series C

Key Investors

Optum Ventures
Lead Investor
Verified investor in Series C
Oxford Science Enterprises
Investor
Verified investor in Series C

About the Author

Editorial Team
Editorial Team
Curated funding news from verified sources